Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06168461
EARLY_PHASE1

Daily Aspirin Treatment After Preeclampsia

Sponsor: Anna Stanhewicz, PhD

View on ClinicalTrials.gov

Summary

Women who develop preeclampsia during pregnancy are four times more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs may be related to lasting blood vessel damage after the pregnancy but there are currently no specific treatment strategies to prevent this disease progression. This study addresses this public health issue by examining whether starting low dose aspirin therapy after pregnancy is an effective treatment for lasting blood vessel damage in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.

Official title: Aspirin for the Treatment of Vascular Dysfunction After Preeclampsia

Key Details

Gender

FEMALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2023-11-01

Completion Date

2026-06

Last Updated

2025-12-15

Healthy Volunteers

No

Conditions

Interventions

DRUG

Aspirin

162mg aspirin capsule

DRUG

Placebo

placebo capsule

Locations (1)

University of Iowa

Iowa City, Iowa, United States